Stay updated on Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Footer revision updated from v3.5.4 to v3.5.5, indicating a new version of the page. No substantive content, including the study details or eligibility criteria, was changed.
    Difference
    0.1%
    Check dated 2026-06-06T13:57:23.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.5.3 to v3.5.4, signaling a new release of the page content.
    Difference
    0.1%
    Check dated 2026-05-15T23:53:51.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.5.2 to v3.5.3, indicating a version/release change to the ClinicalTrials.gov site interface rather than a modification to the study content.
    Difference
    0.1%
    Check dated 2026-04-24T17:10:04.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T13:52:48.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.5.0 on the page.
    Difference
    0.1%
    Check dated 2026-03-19T19:40:43.000Z thumbnail image
  8. Check
    119 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, a routine system update with no user-facing changes to content or studies.
    Difference
    0.1%
    Check dated 2026-02-12T01:40:39.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Idelalisib in Lung Cancer Clinical Trial page.